CO-OLMESARTAN AMLO Spirig HC 20/5/12.5mg 100 pce
7680674470021
CH-67447
C09DX03
02.07.2.
Reimbursement limitations:
COOLMAMLSPIR
Le traitement combiné d’une association fixe d’olmésartan-amlodipine ou d’olmésartan-amlodipine-hydrochlorothiazide et d'un antagoniste du calcium I.T. …
1 / 2
google
Details
- Product number
- 6744701
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- olmesartanum medoxomilum 20 mg, amlodipinum 5 mg ut amlodipini besilas, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, crospovidonum, silica colloidalis anhydrica, magnesii stearas, lactosum monohydricum 102.565 mg, Überzug: hypromellosum, lactosum monohydricum 1.96 mg, macrogolum 4000, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.
Articles (1)
Co-Olmesartan Amlo Spirig HC 20 mg/5 mg/12.5 mg, Filmtabletten
Filmtabletten
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
12.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
102.565 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.96 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 66.85
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/01/2021
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 67447
- Drug name
- Co-Olmesartan Amlo Spirig HC, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C09DX03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 22/04/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CO-OLMESARTAN AMLO Spirig HC 20/5/12.5mg 100 pce
- Description (DE)
- CO-OLMESARTAN AMLO Spirig HC 20/5/12.5mg 100 Stk
- Market launch
- 22/04/2020
- Narcotic (BTM)
- No